Literature DB >> 30090701

Suspicion of mitochondrial disease remains frequently unconfirmed after whole exome sequencing.

Josef Finsterer1, Sinda Zarrouk-Mahjoub2.   

Abstract

Entities:  

Keywords:  Genotype; Mitochondrial; Phenotype; Whole exome sequencing; lactic acidosis; mtDNA depletion; multisystem disease

Year:  2018        PMID: 30090701      PMCID: PMC6078051          DOI: 10.1016/j.ymgmr.2018.07.005

Source DB:  PubMed          Journal:  Mol Genet Metab Rep        ISSN: 2214-4269


× No keyword cloud information.
Letter to the Editor, We read with interest the article by Pausepp et al. about 28 patients with suspected mitochondrial disorder (MID) who retrospectively (n = 17) or prospectively (n = 11) had undergone whole exome sequencing (WES) [1]. We have the following comments/concerns. The authors mention that only in 4/28 patients a MID was genetically confirmed [1]. However, in one further patient an ATP6 variant was detected and in another patient mtDNA depletion was detected on muscle biopsy [1]. Furthermore, the PDHA1 carrier should be regarded as a MID [2]. Why were these three patients not included in the MID-group? Only in 5 of 28 patients did the authors detect a mutated gene associated with a MID and in 1 patient a possible mitochondrial depletion syndrome (MDS) was diagnosed? Were any of the genes associated with MDS screened for a mutation [3]? In how many of the 6 patients with a MID was the family history positive for the disease? In the patient carrying the ATP6 mutation, no heteroplasmy rates are provided. In which tissue were heteroplasmy rates determined and was the degree of heteroplasmy compatible with the phenotype? Did the mother of this patient also carry the mutation? Spinal muscular atrophy (SMA) should not be diagnosed upon the muscle biopsy findings. Did the patient with “typical” histological features of SMA also carry a deletion/duplication of the SMN1 gene? Muscle hypotonia was reported in 11 patients [1]. Was hypotonia attributed to a central cause or due to involvement of the peripheral nerves or the muscle? Only one patient had neuropathy but 16 had muscle weakness [1]. Overall, the study may profit from inclusion of the family history, from provision of heteroplasmy rates for the ATP6 variant, and from stressing that clinical assessment with or without scores may falsely suggest MID in a significant number (n = 21) of patients.

Conflict of interest

There are no conflicts of interest.

Funding

No funding was received.

Author contribution

JF: design, literature search, discussion, first draft, SZM:literature search, critical review.
  3 in total

1.  Four novel PDHA1 mutations in pyruvate dehydrogenase deficiency.

Authors:  E Ostergaard; L Birk Moller; H Serap Kalkanoglu-Sivri; A Dursun; M Kibaek; T Thelle; E Christensen; M Duno; F Wibrand
Journal:  J Inherit Metab Dis       Date:  2009-06-11       Impact factor: 4.982

Review 2.  MtDNA-maintenance defects: syndromes and genes.

Authors:  Carlo Viscomi; Massimo Zeviani
Journal:  J Inherit Metab Dis       Date:  2017-03-21       Impact factor: 4.982

3.  Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia.

Authors:  Sanna Puusepp; Karit Reinson; Sander Pajusalu; Ülle Murumets; Eve Õiglane-Shlik; Reet Rein; Inga Talvik; Richard J Rodenburg; Katrin Õunap
Journal:  Mol Genet Metab Rep       Date:  2018-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.